Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Rossetti P, Pampanelli S, Fanelli C et al (2003) Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime
doi: 10.1210/clinem/dgaa692 64 LiuXZhangYZhengSYLinRXieYJChenHet al
Severity varies widely
Tirzepatide is not approved for use during pregnancy due to the lack of human studies and the potential risks observed in animal research
Understanding these effects helps patients set realistic expectations and recognize normal versus concerning symptoms
